SOSV

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

CroBio is an agricultural biotechnology company developing a sustainable solution for managing global agricultural drought. It uses genetically engineered root-associated bacteria to produce biomaterials that retain water in the soil, enhancing crop resilience and reducing irrigation requirements.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Nukoko is a bean-to-bar manufacturer specializing in cocoa-free chocolate. Utilizing UK-sourced ingredients and patent-pending technology, the company produces healthier, environmentally friendly chocolate.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

HausBots Limited, founded in 2017 and based in Birmingham, United Kingdom, specializes in designing and manufacturing wall-climbing robots for painting and decorating across various industries. Their flagship product, the V1 Wall Climbing Robot, is capable of navigating rough surfaces to perform tasks such as exterior and warehouse painting, high-definition visual inspections, and building and infrastructure surveys. The company's mission is to leverage technology to protect and maintain the built environment, enhancing productivity for clients by automating maintenance tasks at height.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2020, Reach Industries is a software development company based in Bristol, UK. It specializes in creating robotics software to enhance scientific productivity and lab efficiency. The platform offers predictive quality analytics, asset monitoring, process optimization, and cloud-based data storage.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Coffee Exchange operates a digital marketplace that aims to revolutionize the global coffee trading industry by promoting transparency and efficiency. The platform facilitates direct trade between coffee producers and roasters, eliminating intermediaries and enabling producers to earn significantly higher revenues. By providing real-time information and streamlining the entire green coffee trading process—from farm gate to consumer—Coffee Exchange enhances the supply chain while reducing costs for roasters. The company's services include coffee evaluation, logistics, customs clearance, quality inspections, and marketing support, ensuring a comprehensive solution for all participants in the trade. Currently, Coffee Exchange has over 1,100 coffee roasters in China engaged with select producers from countries such as Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. The platform is being trialed in the United States, with plans for expansion into the UK and South Korea.

Kyomei is a company based in Oxford, England, focused on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei employs innovative techniques in plant cell biology to scale the production of myoglobin, which enhances the flavor profile of meat alternatives by providing umami. This approach not only aims to improve the taste of plant-based products but also seeks to reduce reliance on carbon-intensive animal agriculture, promoting a more sustainable food system for consumers.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Kutanios is a biotechnology company headquartered in London. It specializes in developing novel compounds for anti-aging, sun care, anti-acne, and skin cleaning products using its proprietary biodegradable molecules technology.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Founded in 2020, SunGreenH2 specializes in developing high-performance electrolysers using nanotechnology and advanced materials. Headquartered in Singapore with offices in Melbourne and London, the company produces green hydrogen at low cost for industries, mobility, and energy storage.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

HausBots Limited, founded in 2017 and based in Birmingham, United Kingdom, specializes in designing and manufacturing wall-climbing robots for painting and decorating across various industries. Their flagship product, the V1 Wall Climbing Robot, is capable of navigating rough surfaces to perform tasks such as exterior and warehouse painting, high-definition visual inspections, and building and infrastructure surveys. The company's mission is to leverage technology to protect and maintain the built environment, enhancing productivity for clients by automating maintenance tasks at height.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Pear Bio is a biotechnology company based in Boston and London. It develops precision medicine-guided therapeutics for hard-to-treat cancers using AI. The company analyzes tumor biopsies and blood to identify new targets, then tests drug candidates directly on patient samples using its proprietary immune-microtumor system.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Bubbleye is a rapidly growing AI startup specializing in mobile marketing solutions. With its research and development headquarters in Taipei and business development teams worldwide, the company focuses on addressing inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye is committed to innovation and disruption in the mobile marketing sector. The firm serves a global clientele of leading game publishers across the Americas, Europe, and Asia. Supported by backers including prominent angel investors and venture funds, Bubbleye is positioned at the forefront of the global mobile user acquisition landscape, leveraging its unique technology and skilled team to significantly enhance marketing performance for its clients.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

Arthronica is a company developing an artificial intelligence-based platform for patient monitoring and rehabilitation, with a focus on arthritis and chronic rheumatic conditions. Its technology uses skeletal tracking, image analysis, and video analysis to monitor and predict key disease activities, supporting objective assessments of swelling and movement. The platform incorporates force-sensing vision and 3D CAD modeling to quantify physical changes and track disease progression for patients and practitioners. By enabling continuous monitoring and data-driven rehabilitation, Arthronica aims to improve clinical decision making and patient outcomes in musculoskeletal care. The company has conducted clinical trials in the United Kingdom and United States to validate its algorithms and system for real-world use.

Coffee Exchange operates a digital marketplace that aims to revolutionize the global coffee trading industry by promoting transparency and efficiency. The platform facilitates direct trade between coffee producers and roasters, eliminating intermediaries and enabling producers to earn significantly higher revenues. By providing real-time information and streamlining the entire green coffee trading process—from farm gate to consumer—Coffee Exchange enhances the supply chain while reducing costs for roasters. The company's services include coffee evaluation, logistics, customs clearance, quality inspections, and marketing support, ensuring a comprehensive solution for all participants in the trade. Currently, Coffee Exchange has over 1,100 coffee roasters in China engaged with select producers from countries such as Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. The platform is being trialed in the United States, with plans for expansion into the UK and South Korea.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Bubbleye is a rapidly growing AI startup specializing in mobile marketing solutions. With its research and development headquarters in Taipei and business development teams worldwide, the company focuses on addressing inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye is committed to innovation and disruption in the mobile marketing sector. The firm serves a global clientele of leading game publishers across the Americas, Europe, and Asia. Supported by backers including prominent angel investors and venture funds, Bubbleye is positioned at the forefront of the global mobile user acquisition landscape, leveraging its unique technology and skilled team to significantly enhance marketing performance for its clients.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Chronomics Ltd is a tech-bio company headquartered in Norwich, United Kingdom, that specializes in developing testing kits and an artificial intelligence platform for DNA methylation analysis. Founded in 2017, the company provides insights into biological age, smoke exposure, and metabolic state, as well as health risks, eye color, and hereditary intolerances. Chronomics aims to make biological information accessible and actionable, simplifying the use of biomarkers across various sectors, including telehealth, travel, and personal care. By partnering with major organizations, Chronomics seeks to enhance how individuals diagnose and personalize their health and wellness decisions, contributing to a broader bio-revolution that aims to transform everyday life through scientific innovation.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Coffee Exchange operates a digital marketplace that aims to revolutionize the global coffee trading industry by promoting transparency and efficiency. The platform facilitates direct trade between coffee producers and roasters, eliminating intermediaries and enabling producers to earn significantly higher revenues. By providing real-time information and streamlining the entire green coffee trading process—from farm gate to consumer—Coffee Exchange enhances the supply chain while reducing costs for roasters. The company's services include coffee evaluation, logistics, customs clearance, quality inspections, and marketing support, ensuring a comprehensive solution for all participants in the trade. Currently, Coffee Exchange has over 1,100 coffee roasters in China engaged with select producers from countries such as Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. The platform is being trialed in the United States, with plans for expansion into the UK and South Korea.

QV Bioelectronics develops an innovative electric field therapy implant, GRACE, designed to extend the lives of brain tumor patients while maintaining their quality of life. This first-of-its-kind device targets glioblastoma, a cancer with poor outcomes, by slowing tumor growth and sparing healthy tissue.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Encelo Laboratories Limited develops and supplies cell isolation tools that enable researchers, clinicians, and pharmaceutical companies to obtain live cells non‑invasively from urine samples. Its flagship product, a cell isolation cup, selectively captures and preserves primary cells for shipment, improving recovery rates compared to conventional methods. The technology supports a range of precision‑medicine applications, including disease diagnostics, drug screening, and regenerative‑medicine research, by providing readily available patient‑specific live cells at scale.

NeuroCreate is a technology company that develops FlowCreate Innovator, an AI-powered platform that applies neuroscience to enhance cognition, creativity, and workflow. The platform provides digital tools to support strategizing, problem solving, and idea generation, aiming to help users reach a flow state more quickly and sustain high performance. By combining artificial intelligence, neuroscience, and design, NeuroCreate seeks to improve digital health and mental flexibility, offering personalized experiences that promote wellbeing and productivity. The company emphasizes human-centered AI and ethical product design, with a focus on inclusive access to peak cognitive performance. Founded in 2017 and based in London, NeuroCreate positions its solutions as enabling professionals to augment work processes, accelerate learning, and explore creativity through NeuroDesign, a framework that translates neuroscience into practical digital products.

VisusNano Ltd. is a London-based company founded in 2016 that specializes in the development of a drug-eluting intraocular lens implant designed for use in cataract surgery. This innovative technology aims to enhance patient outcomes by reducing the risks associated with the procedure, such as intraocular inflammation, infection, and opacification. By eliminating the need for postoperative eye drops and minimizing the necessity for laser treatments, VisusNano's product has the potential to transform cataract surgery for both human and veterinary patients. The company is currently in the pre-clinical stage of its development.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Chronomics Ltd is a tech-bio company headquartered in Norwich, United Kingdom, that specializes in developing testing kits and an artificial intelligence platform for DNA methylation analysis. Founded in 2017, the company provides insights into biological age, smoke exposure, and metabolic state, as well as health risks, eye color, and hereditary intolerances. Chronomics aims to make biological information accessible and actionable, simplifying the use of biomarkers across various sectors, including telehealth, travel, and personal care. By partnering with major organizations, Chronomics seeks to enhance how individuals diagnose and personalize their health and wellness decisions, contributing to a broader bio-revolution that aims to transform everyday life through scientific innovation.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Aptapp specialises in creating solutions that add Mobility to Commerce. Their experts and solutions help stimulate growth, maximise returns, and ensure long term sustainable evolution of Businesses. With offices in India and United Kingdom, Team Aptapp is an optimal mix of seasoned business and technical professionals boasting diverse experiences from around the Globe

Bubbleye is a rapidly growing AI startup specializing in mobile marketing solutions. With its research and development headquarters in Taipei and business development teams worldwide, the company focuses on addressing inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye is committed to innovation and disruption in the mobile marketing sector. The firm serves a global clientele of leading game publishers across the Americas, Europe, and Asia. Supported by backers including prominent angel investors and venture funds, Bubbleye is positioned at the forefront of the global mobile user acquisition landscape, leveraging its unique technology and skilled team to significantly enhance marketing performance for its clients.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Kokoon Technology Limited, established in 2013 and headquartered in London, specializes in sleep technology. The company manufactures headphones equipped with EEG brainwave sensing technology and movement sensors, enabling precise sleep monitoring. Kokoon's products include active noise cancellation, noise isolation, and active white noise features, along with a mobile app offering a relaxation audio library and personalized sleep analysis. The company aims to make sleep science more accessible and enjoyable, delivering personalized audio coaching and experiences through its app-based software platform.

Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Gamer Guides is a publisher based in Manchester, UK, specializing in creating interactive digital strategy guides for video games. The company provides these guides through its iOS app and website, offering gaming professionals and enthusiasts a comprehensive source for strategies, walkthroughs, and game information.

Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Breather Products Inc. is a company that specializes in providing on-demand private workspaces designed for productivity. Founded in 2012 and headquartered in Montreal, Canada, Breather has established a network of flexible office spaces available for reservation via its web and mobile applications. The company's offerings allow clients to rent spaces by the hour, day, or month, catering to various business needs. With locations in major cities, including New York, San Francisco, Los Angeles, Boston, Chicago, Washington, Toronto, Montreal, and London, each workspace is equipped with essential technology to facilitate immediate productivity. Breather aims to create comfortable and private environments that enhance operational efficiency for businesses and corporate clients.

Gamer Guides is a publisher based in Manchester, UK, specializing in creating interactive digital strategy guides for video games. The company provides these guides through its iOS app and website, offering gaming professionals and enthusiasts a comprehensive source for strategies, walkthroughs, and game information.

Gamer Guides is a publisher based in Manchester, UK, specializing in creating interactive digital strategy guides for video games. The company provides these guides through its iOS app and website, offering gaming professionals and enthusiasts a comprehensive source for strategies, walkthroughs, and game information.

Zartis is a global digital solutions provider specializing in bespoke software development teams. With expertise across various technologies and cloud architectures, they offer services including application development, software architecture, CI/CD, business intelligence, QA automation, and new technology integrations. Zartis partners with diverse industries, delivering innovative tech solutions through their engineering hubs in Ireland, Spain, and Poland.

Made To Fit Me is a clothing company based in Market Drayton, United Kingdom, specializing in the distribution of tailored dresses for women through both online and offline channels. The company focuses on mass market customization in women's fashion, addressing the common issue of limited size options in traditional retail. By offering a straightforward online measuring process, Made To Fit Me eliminates the uncertainty associated with finding the perfect fit, allowing customers to receive unique, one-of-a-kind garments tailored to their individual size and preferences. The dresses are crafted from ethically sourced materials, empowering women to express their personal style while enhancing their confidence.